publication date: May. 16, 2014

No Justification Provided

By Matthew Bin Han Ong

The American Association of University Professors sent a letter to Ronald DePinho, president of MD Anderson Cancer Center, urging the reinstatement of two faculty members who were denied tenure renewal without stated reasons.

The letter is a part of AAUP’s response to a request for an investigation, which was triggered by the administration’s refusal to provide justification for denying tenure renewals to faculty who received unanimous votes for renewal from the Faculty Senate Promotions & Tenure Committee (The Cancer Letter, April 25).

The investigation was requested by Douglas Boyd, a professor in the MD Anderson Department of Cancer Biology and chair of the PTC Issues Committee. In an email to AAUP, Boyd outlined his case for the investigation with meeting minutes and presentations.

The AAUP letter, dated May 13, begins with description of the cases of the two affected faculty members—Kapil Mehta and Zhengxin Wang—whose tenure renewal applications were vetoed by DePinho.

“Our Association’s interest in the cases of Professor Mehta and Professor Wang stems from its commitment to basic tenets of academic freedom, tenure, and due process, as enunciated in the 1940 Statement of Principles on Academic Freedom and Tenure, jointly formulated by the AAUP and Association of American Colleges and Universities (AAC&U) and endorsed by several hundred educational and scholarly organizations,” said the letter from Gregory Scholtz, AAUP associate secretary and director of the Department of Academic Freedom, Tenure, and Governance.

MD Anderson may join over 50 institutions … Continue reading 40-20 No Justification Provided AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.